| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/15/2002 | US20020110526 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110524 Method for stabilizing biomolecules in liquid formulations |
| 08/15/2002 | US20020108217 Jewelry closure |
| 08/15/2002 | CA2437750A1 Prc17: an amplified cancer gene |
| 08/15/2002 | CA2437727A1 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437714A1 Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof |
| 08/15/2002 | CA2437573A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437572A1 Method for the production of plant seed with modified fibre content and modified seed coat |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437570A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437564A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/15/2002 | CA2437497A1 Lipid-associated molecules |
| 08/15/2002 | CA2437423A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 08/15/2002 | CA2437276A1 Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof |
| 08/15/2002 | CA2437272A1 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | CA2437270A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | CA2437265A1 Modified leptin with reduced immunogenicity |
| 08/15/2002 | CA2437263A1 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | CA2437214A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | CA2437185A1 Timm8b-related protein |
| 08/15/2002 | CA2437015A1 Combined use of factor vii polypeptides and factor ix polypeptides |
| 08/15/2002 | CA2436807A1 Combined use of factor vii polypeptides and factor viii polypeptides |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2436465A1 Prediction of wound healing by urinary nitrate assay |
| 08/15/2002 | CA2436334A1 Adhesion molecules |
| 08/15/2002 | CA2435982A1 Medicaments |
| 08/15/2002 | CA2435835A1 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| 08/15/2002 | CA2435563A1 Long lasting growth hormone releasing factor derivatives |
| 08/15/2002 | CA2434944A1 Secreted proteins |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/15/2002 | CA2405524A1 A personal condition management system |
| 08/14/2002 | EP1231279A1 Process for producing tripeptides |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1231275A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1231274A2 Modified porteinase inhibitors |
| 08/14/2002 | EP1231270A1 Novel protein and dna thereof |
| 08/14/2002 | EP1231269A1 Methods and compositions for polypeptide engineering |
| 08/14/2002 | EP1231268A2 Polyclonal antibody libraries |
| 08/14/2002 | EP1231220A1 Modified factor VIII cDNa and its use for the production of factor VIII |
| 08/14/2002 | EP1231219A1 GLucagon-like peptide-2 analogs |
| 08/14/2002 | EP1231218A2 An appetite-suppressing peptide, its compositions and use |
| 08/14/2002 | EP1231217A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1231216A2 Human gtp-rho binding protein 2 |
| 08/14/2002 | EP1230930A2 Bmp-9 compositions |
| 08/14/2002 | EP1230929A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 08/14/2002 | EP1230928A1 Use of peptide |
| 08/14/2002 | EP1230917A1 Invasomes for the therapy of illnesses, their manufacture and use |
| 08/14/2002 | EP1230394A1 Lentiviral vector transduction of hematopoietic stem cells |
| 08/14/2002 | EP1230389A1 Antisense inhibition of pi3 kinase p55 gamma expression |
| 08/14/2002 | EP1230375A1 Inhibiting gene expression with dsrna |
| 08/14/2002 | EP1230370A2 Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
| 08/14/2002 | EP1230369A2 Polypeptide hormone phosphatonin |
| 08/14/2002 | EP1230368A2 Mammalian receptor proteins; related reagents and methods |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230364A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/14/2002 | EP1230362A2 Human zven proteins |
| 08/14/2002 | EP1230361A2 G protein-coupled receptors expressed in human brain |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230359A1 Chordin-like homologs |
| 08/14/2002 | EP1230358A2 N-cam homolog and splice variants thereof |
| 08/14/2002 | EP1230357A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 08/14/2002 | EP1230356A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230271A1 Hedgehog fusion proteins and uses |
| 08/14/2002 | EP1230268A2 Heteroclitic analogs of class i epitopes |
| 08/14/2002 | EP1230267A2 Membrane translocating peptide drug delivery system |
| 08/14/2002 | EP1230266A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 08/14/2002 | EP1230264A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 08/14/2002 | EP1230263A1 A novel molecule |
| 08/14/2002 | EP1230262A2 Biglycan and related therapeutics and methods of use |
| 08/14/2002 | EP1230260A1 Hcv ns3 protease inhibitors |
| 08/14/2002 | EP1230259A1 S-allylmercaptoglutathione and uses thereof |
| 08/14/2002 | EP1230255A1 25 human secreted proteins |
| 08/14/2002 | EP1230254A1 Antisense modulation of src-3 expression |
| 08/14/2002 | EP1230242A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229965A2 Placental human neurokinin b precursor |
| 08/14/2002 | EP1229941A2 Nucleic acid-containing complex |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229927A1 Use of a growth hormone or a growth hormone secretagogue for appetite-suppression or induction of satiety |
| 08/14/2002 | EP1229926A1 Pharmaceutical composition for treatment of diarrhea |
| 08/14/2002 | EP1229925A2 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 08/14/2002 | EP1229922A2 Aplidine treatment of cancers |
| 08/14/2002 | EP1229920A1 Therapy with 2-5a and interferon |
| 08/14/2002 | EP1229906A2 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders |
| 08/14/2002 | EP1229895A1 Slimming composition containing a substance inducing il-6 production |
| 08/14/2002 | EP1229890A1 Dyeing composition promoting natural pigmentation, method for obtaining same and use for colouring the skin and/or keratinous fibres |
| 08/14/2002 | EP1229795A2 Human chemokine beta-13 |
| 08/14/2002 | EP1229790A1 MODULATION OF $g(g)$g(d) T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| 08/14/2002 | EP1187591A4 Ibd-associated microbial antigens and methods of using same |
| 08/14/2002 | EP1096951B1 Use of bromelain proteases for inhibiting blood coagulation |
| 08/14/2002 | EP1077718B1 Enhancement of oxazolidinone antibacterial agents activity by arginine derivatives |
| 08/14/2002 | EP1067955B1 Use of erythropoietin in the treatment of multiple myeloma |
| 08/14/2002 | EP0977582B1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 08/14/2002 | EP0959898A4 Lactoferrin variants and uses thereof |
| 08/14/2002 | EP0922054B1 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 08/14/2002 | EP0831879B1 Method for identifying or isolating a molecule and molecules identified thereby |
| 08/14/2002 | EP0817614B1 Stable protein-phospholipid compositions and method of preparation |